An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R. Good, Carl H. June, Shunichiro Kuramitsu et al.|Cell|2021Cited by 398
Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T CellsKeisuke Watanabe, Makoto Murata|The Journal of Immunology|2014Cited by 283
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenovirusesKeisuke Watanabe, Carl H. June|JCI Insight|2018Cited by 279